BIOORGANIC & MEDICINAL CHEMISTRY LETTERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2022-02-15 ms9000000965481213

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：医学;药学;核药学
经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收
总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。

55 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

RUNNINGTITLE和TITLE的区别？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

RUNINGTITLE的撰写方法？

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2021-01-28 120b32aem81暂无昵称

有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2021-08-27 Orca_Y

一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间...

64 0

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2021-03-03 夏柔shero

请问大佬们：
1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？
2.这个杂志需要提供WB原始图片吗？全膜还是？
3.我看可以自己选编辑，大家有推荐的编辑吗？

131 0

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2019-05-10 145d49a7m79暂无昵称

请问，with journal意思是编辑都还没有看吗？

200 0

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2018-05-16 ms3867726040880872

审稿速度:2.0 | 投稿命中率:25.0
经验分享：请问这个期刊现在需要版面费吗？收费吗？

133 0

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2018-01-24 南京药化

为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？

357 0

[GetPortalCommentsPageByObjectIdResponse(id=1193504, encodeId=8c0a119350431, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：医学;药学;核药学 经验分享：2021.11.25. submit 投稿，2022.1.15. 大修修回，2022.2.14. 接收 总体来说，投稿速度较快，编辑和审稿人很好，希望期刊越来越好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15705506784, createdName=ms9000000965481213, createdTime=Tue Feb 15 10:07:42 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088005, encodeId=9e701088005e1, content=RUNNINGTITLE和TITLE的区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088006, encodeId=532810880067b, content=RUNINGTITLE的撰写方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920725, encodeId=065f920e25ae, content=有人投过这个杂志嘛？我1月26号投的，一直是submit to journal，感觉很慢啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=577e2200579, createdName=120b32aem81暂无昵称, createdTime=Thu Jan 28 12:31:25 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012052, encodeId=51081012052c0, content=一审三个多月还没结果，under review状态半个月一变... 拒得爽快也好啊...卡在这儿好耽误时间..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6af65478781, createdName=Orca_Y, createdTime=Fri Aug 27 14:09:37 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945145, encodeId=21f9945145f0, content=请问大佬们： 1.这个杂志接受中药单体抗肿瘤的细胞动物实验吗？ 2.这个杂志需要提供WB原始图片吗？全膜还是？ 3.我看可以自己选编辑，大家有推荐的编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211101/e228b8121c654b35a6eaa46215dad5b3/53efd70b9a864f5e9c70929197799b51.jpg, createdBy=f1c35310723, createdName=夏柔shero, createdTime=Wed Mar 03 15:24:42 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570737, encodeId=87ea5e0737fc, content=请问，with journal意思是编辑都还没有看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aba5091634, createdName=145d49a7m79暂无昵称, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843144, encodeId=8b918431444f, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问这个期刊现在需要版面费吗？收费吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a45a5414149, createdName=ms3867726040880872, createdTime=Wed May 16 17:06:42 CST 2018, time=2018-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551918, encodeId=b8635519181e, content=为什么不能选择研究领域？？？Select Personal Classifications？？？选不了，怎么回事？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4411972671, createdName=南京药化, createdTime=Wed Jan 24 10:56:00 CST 2018, time=2018-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839138, encodeId=2a4583913870, content=垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84af5414040, createdName=ms1437042654898988, createdTime=Tue Nov 07 13:57:40 CST 2017, time=2017-11-07, status=1, ipAttribution=)]

2017-11-07 ms1437042654898988

垃圾杂志，灌水乐园~~~写基金千万别写这个，容易被毙掉

131 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务